| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/31/2008 | WO2007089652A3 Flavor-enhancing compositions, methods of manufacture, and methods of use |
| 01/31/2008 | WO2007087250A3 Tricyclic inhibitors of 5-lipoxygenase |
| 01/31/2008 | WO2007081946A3 Method for the identification of drugs to treat stroke at delayed timepoints |
| 01/31/2008 | WO2007079141A3 Method of identifying compounds useful to treat neuronal degenerative diseases |
| 01/31/2008 | WO2007075808A3 Methods for preventing and/or treating a cell proliferative disorder |
| 01/31/2008 | WO2007075720A3 Topical mecamylamine formulations for ocular administration and uses thereof |
| 01/31/2008 | WO2007075459A3 5-aryl isoxazolines for controlling invertebrate pests |
| 01/31/2008 | WO2007067757A3 Certain chemical entities, compositions, and methods for modulating trpv1 |
| 01/31/2008 | WO2007067333A3 Trioxane dimers having high anticancer and long-lasting antimalarial activities |
| 01/31/2008 | WO2007064741A8 The use of bacillus pb6 for the prophylaxis or treatment of gastrointestinal and immuno-related diseases |
| 01/31/2008 | WO2007062015A3 Methods of treating ischemic related conditions |
| 01/31/2008 | WO2007048524A3 Wound-healing pharmaceutical compositions in the form of a sterile powder based on amino acids and sodium hyaluronate |
| 01/31/2008 | WO2007020671B1 Ophthalmic compositions containing mucoadhesive polysaccharides able to promote corneal re-epithelization |
| 01/31/2008 | WO2007002559A8 Pyrazole based lxr modulators |
| 01/31/2008 | WO2006110814A3 Methods for treating diseases through inhibition the function of molecular chaperones such as protein disulfide isomerases, pharmaceutical compositions comprising them, and screening methods for identifying therapeutic agents |
| 01/31/2008 | WO2006107753A3 Pyrazolopyridines and analogs thereof |
| 01/31/2008 | WO2006094917A8 Oligodeoxyribonucleotides of 4000-10000 dalton for treating tumors |
| 01/31/2008 | WO2006091571A3 Methods for selectively treating cox-2 mediated disorders by administering gamma-tocopherol |
| 01/31/2008 | WO2005084377A3 Combination therapy with glatiramer acetate and riluzole |
| 01/31/2008 | US20080027371 Method and device for minimally invasive site specific ocular drug delivery |
| 01/31/2008 | US20080027237 Processes for preparations of 9,11-epoxy steroids and intermediates useful therein |
| 01/31/2008 | US20080027232 Reacting a dialkylboron-X where X is a leaving group with a 1-acyldipyrromethane; complex formed may be combined with a hindered alkyl amine base, such as triethylamine, diisopropylethylamine, or triphenylamine, in an organic solvent to form a solid; product may be decomplexed by contact with an OH |
| 01/31/2008 | US20080027229 Compounds for the treatment of metabolic disorders |
| 01/31/2008 | US20080027228 Substituted thioacetamides |
| 01/31/2008 | US20080027224 silyl camptothecin derivatives for cancer and/or leukemia; cytotoxic; DNA-topoisomerase I inhibitors; antitumor agents; 7-trimethylsilyl-10-acetoxy camptothecin, 7-trimethylsilyl-11-fluoro camptothecin |
| 01/31/2008 | US20080027214 Modulation of immunostimulatory activity of immunostimulatory Oligonucleotide analogs by positional chemical changes |
| 01/31/2008 | US20080027143 Chemical formulation for an insecticide |
| 01/31/2008 | US20080027141 1,3-Dihydroxyl-9,10-anthraquinone and 3-[(3-amino)-propoxy]- 9,10-anthraquinone derivatives and pharmaceutical compositions comprising the same |
| 01/31/2008 | US20080027140 Combinations of Serotonin Reuptake Inhibitors and Imidazoline I 2 Agonists |
| 01/31/2008 | US20080027139 Use of Alpha-Ketoglutarate and Related Compounds |
| 01/31/2008 | US20080027138 Novel NIDDM Regimen |
| 01/31/2008 | US20080027137 From 2-(N-protected amino)-3-methoxypropionic acid; improved enantiomeric purity; O-methylation of serine derivatives |
| 01/31/2008 | US20080027136 Compositions and methods for the treatment of cystic fibrosis |
| 01/31/2008 | US20080027135 Methods For Identifying Chemical Modulators Of Ras Superfamily Gptase Activity |
| 01/31/2008 | US20080027134 Hydroxybiphenyl carboxylic acids and derivatives, method for producing the same and their use |
| 01/31/2008 | US20080027133 Use of chromen-4-one derivatives |
| 01/31/2008 | US20080027132 1,1,1,3,3,3-hexachloro-2-methylpropan-2-yl 4-((4-hydroxy-2-oxo-2H-chromen-3-yl)methyl)benzoate; side effect reduction over warfarin |
| 01/31/2008 | US20080027131 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity |
| 01/31/2008 | US20080027130 Cytotoxic agents comprising taxanes and their therapeutic use |
| 01/31/2008 | US20080027129 Administration of 3H-1, 2-dithiole-3-thione, anethole dithiolethione, sulforaphane, phenethyl isothiocyanate, 6-(methylsulfinyl)hexyl isothiocyanate and allyl isothiocyanate for the treatment of canities |
| 01/31/2008 | US20080027128 Duloxetine HCL polymorphs |
| 01/31/2008 | US20080027127 Trans Pyrrolidinyl Derivates and Their Pharmaceutical Use |
| 01/31/2008 | US20080027126 Pyrrolidin-2-One Derivatives for Use as Dp1 Receptor Agonists |
| 01/31/2008 | US20080027125 Fluvastatin sodium novel forms and preparation thereof |
| 01/31/2008 | US20080027124 3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase i |
| 01/31/2008 | US20080027123 Reduction of levels of tumor necrosis factor-alpha and/or inhibition of phosphodiesterase 4; treating erythema nodosum leprosum in leprosy, rhematoid spondylitis, hepatitis or congestive heart failure |
| 01/31/2008 | US20080027122 antidiabetic agents; 4-chloro-3-(4-ethylphenylmethyl)-1-( beta -D-glucopyranosyl)indole; hypoglycemic agent, wound healing agent, antilipemic agents, hypotensive agent; chemical synthesis with a chemical intermediates |
| 01/31/2008 | US20080027121 Novel pyrone-indole derivatives and process for their preparation |
| 01/31/2008 | US20080027120 Ketorolac tromethamine compositions for treating or preventing ocular pain |
| 01/31/2008 | US20080027119 Methods and compositions employing bicifadine for the treatment of acute pain, chronic pain, and symptoms of neuropathic disorders |
| 01/31/2008 | US20080027118 Prodrugs Of Mitotic Kinesin Inhibitors |
| 01/31/2008 | US20080027116 Pharmaceutical Composition for Treating Spinocerebellar Ataxia |
| 01/31/2008 | US20080027115 Combinatorial libraries of autoinducer analogs, autoinducer agonists and antagonists, and methods of use thereof |
| 01/31/2008 | US20080027114 Active Agent Combinations with Insecticidal and Acaricidal Properties |
| 01/31/2008 | US20080027113 Methods of Using and Compositions Comprising Immunomodulatory Compounds for Treatment and Management of Macular Degeneration |
| 01/31/2008 | US20080027112 enzyme inhibitors of phosphodiesterase 4; antiinflammatory agent for the treatment or prevention of inflammatory diseases and other diseases involving elevated levels of cytokines |
| 01/31/2008 | US20080027111 Treatment and prevention of cardiovascular disease using mast cell stabilizers |
| 01/31/2008 | US20080027110 Indolyl-3-glyoxylic acid derivatives having antitumor action |
| 01/31/2008 | US20080027109 bis-[2-(pivaloylamino)phenyl]disulfide; cholesteryl ester transfer protein (CETP); atherosclerosis, hyperlipidemia |
| 01/31/2008 | US20080027108 Therapeutic substituted lactams |
| 01/31/2008 | US20080027107 With nitrogen containing heterocyclic substituents; for example, 1-{[(2-dimethylamino)ethyl]amino}-4-{[2-(3-hydroxypiperidin-1-yl)ethyl]amino}-anthracene-9,10-dione |
| 01/31/2008 | US20080027106 Methods of treating psychosis and schizphrenia based on polymorphisms in the cntf gene |
| 01/31/2008 | US20080027105 Dosing Regimen of Flavopiridol for Treating Cancer` |
| 01/31/2008 | US20080027104 Novel Crystalline Forms 2 |
| 01/31/2008 | US20080027103 Novel Crystalline Forms 1 |
| 01/31/2008 | US20080027102 Quinolinyl-pyrrolopyrazoles |
| 01/31/2008 | US20080027101 Xinafoate salt of a substituted 5-oxazol-2-yl-quinoline compound |
| 01/31/2008 | US20080027100 Functionally selective alpha2C adrenoreceptor agonists |
| 01/31/2008 | US20080027099 Bicyclic heteroaryl inhibitors of pde4 |
| 01/31/2008 | US20080027098 Derivatives of alpha-phenylthiocarboxylic and alpha-phenyloxy-carboxylic acids useful for the treatment of diseases responding to PPARalpha activation |
| 01/31/2008 | US20080027097 Pharmaceutical drug candidates and methods for preparation thereof |
| 01/31/2008 | US20080027096 Novel Pharmaceutical Compositions |
| 01/31/2008 | US20080027095 Use Of 3-Substituted-2-(Diphenylmethy)-1-Azabicyclo[2.2.2]Octanes For Treating Mrg-X1 Receptor Mediated Diseases |
| 01/31/2008 | US20080027094 Tropane Compounds and Pharmaceutical Compositions Comprising the Same as an Active Ingredient |
| 01/31/2008 | US20080027093 Cyclohexylalanine Derivatives as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes |
| 01/31/2008 | US20080027092 1-Acetic Acid-Indole, -Indazole and -Benzimidazole Derivatives Useful for the Treatment of Respiratory Disorders |
| 01/31/2008 | US20080027091 Soft anticholinergic zwitterions |
| 01/31/2008 | US20080027090 N-5,6,9,10,11,12-hexahydro-4H,8H-cyclohepta[4,5]pyrrolo[3,2,1-ij]quinolin-2-yl-3,3-dimethylbutanamide; for treating cardiovascular disorders, nervous system disorders e.g epilepsy, episodic ataxia type 1, paroxysmal dyskinesia, neurodegenerative spincerebrallar ataxia, Parkinson's disease |
| 01/31/2008 | US20080027089 Formed by reacting rapamycin or an analog with an optionally substituted olefin to fuse the C26NO2 ring with a vinylene group to form a fused cyclohexene ring, which may then be hydrogenated to a cyclohexane ring; neuroprotective agents |
| 01/31/2008 | US20080027088 Imidazole-Based Hmg-Coa Reductase Inhibitors |
| 01/31/2008 | US20080027087 CB1 antagonists and inverse agonists |
| 01/31/2008 | US20080027086 Farnesyl transferase inhibiting tricyclic quinazoline derivatives substituted with carbon-linked imidazoles or triazoles |
| 01/31/2008 | US20080027084 antiinflammatory agent, anticarcinogenic agent; for treating inflammatory diseases, allergic, autoimmune, metabolic, cancer, cardiovascular diseases |
| 01/31/2008 | US20080027083 Modulators of chemokine receptor activity crystalline forms and process |
| 01/31/2008 | US20080027082 Use of adenosine a1 antagonists in radiocontrast media induced nephropathy |
| 01/31/2008 | US20080027081 Therapeutic compounds |
| 01/31/2008 | US20080027080 Cyclic derivatives as modulators of chemokine receptor activity |
| 01/31/2008 | US20080027079 Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity |
| 01/31/2008 | US20080027078 9-[2-(1H-indol-3-yl)ethyl]-2-pyridin-4-yl-6,7,8,9-tetrahydro-4H-pyrimido[1,2-a]pyrimidin-4-one; glycogen synthase kinase 3 beta inhibitors; nerve growth factors; neurodegenerative diseases; Alzheimer's disease; Parkinson's disease; tauopathies; stroke; vision defects;antidiabetic agent; anticarcinogenic |
| 01/31/2008 | US20080027077 Novel biaromatic compounds that modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 01/31/2008 | US20080027076 Pyrimidines With Tie2 (Tek) Activity |
| 01/31/2008 | US20080027075 Quaternary Amino-Function Chalcones |
| 01/31/2008 | US20080027074 3-(2-piperazin-1-yl-phenylsulfanyl)-1H-indole; 3-(2-piperazin-1-yl-phenylsulfanyl)-1H-indole-7-carboxylic acid methyl ester; attention deficit hyperactivity disorder (ADHD); serotonin, norepinephrine and/or dopamine reuptake inhibitors reuptake inhibitors |
| 01/31/2008 | US20080027073 Substituted indanyl sulfonamide compounds, their preparation and use as medicaments |
| 01/31/2008 | US20080027072 Potentiation of MC4 receptor activity |
| 01/31/2008 | US20080027071 2-{2-[4-(2,3-Dihydrobenzo[1,4]dioxin-5-yl)piperazin-1-yl]ethylsulfanyl}-6-methylnicotinonitrile; serotonin and dopamine receptor antagonist, serotonin reuptake inhibitor; anxiolytic agent, antidepressant; panic and obsessive compulsive disorder, social phobia, eating disorders, psychosis |
| 01/31/2008 | US20080027070 2-amino--5-substituted pyrimidine inhibitors |
| 01/31/2008 | US20080027069 Quinazoline compounds |
| 01/31/2008 | US20080027068 Heterocyclic compounds and thrombopoietin receptor activators |
| 01/31/2008 | US20080027067 Heterocyclic derivatives as modulators of ion channels |